Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
News provided by
Share this article
Share this article
CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders, Kathy He, Richard Lee, MD, and Dana Zhang, MD, to its expanding team. Ms. He joins Kira as Chief Business Officer; Dr. Lee joins as Chief Medical Officer; and Dr. Zhang as Chief Commercial Officer, China, strengthening the executive team at a key time of growth for the company.